4//SEC Filing
BIO LOGIC SYSTEMS CORP 4
Accession 0001181431-06-002062
CIK 0000355007operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:32 PM ET
Size
19.9 KB
Accession
0001181431-06-002062
Insider Transaction Report
Form 4
DAMRON LAWRENCE D
Director
Transactions
- Disposition to Issuer
Common Stock, $0.01 par value
2006-01-05−2,500→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2006-01-05$5.52/sh−15,750$86,992→ 0 totalExercise: $3.25Exp: 2012-02-19→ Common Stock (15,750 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2006-01-05$5.44/sh−3,750$20,388→ 0 totalExercise: $3.33Exp: 2013-03-03→ Common Stock (3,750 underlying)
Footnotes (7)
- [F1]Disposed of pursuant to the merger agreement among Issuer, Natus Medical Incorporated and Summer Acquisition Corporation, in which each share of common stock of the Issuer was exchanged for $8.77 in cash, without interest, on the effective date of the merger.
- [F2]This option, which provided for vesting in four equal annual installments beginning February 19, 2003, was cancelled in the merger in exchange for a cash payment of $86,991.98, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.2467) and the per share merger consideration ($8.77).
- [F3]This option, which provided for vesting in four equal annual installments beginning March 3, 2004, was cancelled in the merger in exchange for a cash payment of $20,387.63, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.333) and the per share merger consideration ($8.77).
- [F4]This option, which provided for vesting in four equal annual installments beginning August 8, 2004, was cancelled in the merger in exchange for a cash payment of $20,562.38, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.2867) and the per share merger consideration ($8.77).
- [F5]This option, which provided for vesting in four equal annual installments beginning March 1, 2005, was cancelled in the merger in exchange for a cash payment of $18,012.38, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.9667) and the per share merger consideration ($8.77).
- [F6]This option, which provided for vesting in four equal annual installments beginning July 22, 2005, was cancelled in the merger in exchange for a cash payment of $18,262.50, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($3.90) and the per share merger consideration ($8.77).
- [F7]This option, which provided for vesting in four equal annual installments to begin on March 1, 2006, was cancelled in the merger in exchange for a cash payment of $8,962.50, representing the number of underlying shares of common stock multiplied by the difference between the exercise price of the option ($6.38) and the per share merger consideration ($8.77).
Documents
Issuer
BIO LOGIC SYSTEMS CORP
CIK 0000355007
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000355007
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:32 PM ET
- Size
- 19.9 KB